They observed that MDD patients showed increased expression levels of OXTR and confirmed deregulation in the oxytocinergic signalling, referring to signalling pathway proteins including oxytocin, oxytocin receptors and related regulatory factors. The gene discussed is OXTR; the disease is major depressive disorder.